INVO Fertility, Inc. (IVF) is a Healthcare · Medical Devices company listed on NASDAQ. Price $0.98 (+5.32%), Market cap $0.00B, 52-week low–high $0.25 ~ $3.46.
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was form
Financial statements, price targets, institutional (13F) holdings and related news for INVO Fertility, Inc. are updated in real time on BlackAll Trade.
INVO Fertility, Inc. trades at $0.98 (+5.32%). Real-time quotes and charts are available on BlackAll Trade.
INVO Fertility, Inc. has a market cap of about $0.00B.
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services